Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor.

Oyanagi J, Kojima N, Sato H, Higashi S, Kikuchi K, Sakai K, Matsumoto K, Miyazaki K.

Exp Cell Res. 2014 Aug 15;326(2):267-79. doi: 10.1016/j.yexcr.2014.04.009. Epub 2014 Apr 26.

PMID:
24780821
2.

Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.

Cheng N, Chytil A, Shyr Y, Joly A, Moses HL.

Mol Cancer Res. 2008 Oct;6(10):1521-33. doi: 10.1158/1541-7786.MCR-07-2203.

3.

Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells.

Inoue T, Chung YS, Yashiro M, Nishimura S, Hasuma T, Otani S, Sowa M.

Jpn J Cancer Res. 1997 Feb;88(2):152-9.

PMID:
9119743
4.
5.

Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production.

Qian LW, Mizumoto K, Maehara N, Ohuchida K, Inadome N, Saimura M, Nagai E, Matsumoto K, Nakamura T, Tanaka M.

Cancer Lett. 2003 Feb 10;190(1):105-12.

PMID:
12536083
6.

Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.

Matise LA, Palmer TD, Ashby WJ, Nashabi A, Chytil A, Aakre M, Pickup MW, Gorska AE, Zijlstra A, Moses HL.

Breast Cancer Res. 2012 Jul 2;14(4):R98. doi: 10.1186/bcr3217.

7.

[Role of hepatocyte growth factor in invasion of prostate cancer cell lines through tumor-stromal interaction].

Nishimura K, Takada S, Miura H, Tsujimura A, Kitamura M, Nonomura N, Matsumiya K, Okuyama A.

Hinyokika Kiyo. 2000 Oct;46(10):769-74. Japanese.

PMID:
11215208
9.

Hepatocyte growth factor in lung morphogenesis and tumor invasion: role as a mediator in epithelium-mesenchyme and tumor-stroma interactions.

Matsumoto K, Date K, Ohmichi H, Nakamura T.

Cancer Chemother Pharmacol. 1996;38 Suppl:S42-7. Review.

PMID:
8765416
10.

Prostate stromal cell-derived hepatocyte growth factor induces invasion of prostate cancer cell line DU145 through tumor-stromal interaction.

Nishimura K, Kitamura M, Miura H, Nonomura N, Takada S, Takahara S, Matsumoto K, Nakamura T, Matsumiya K.

Prostate. 1999 Nov 1;41(3):145-53.

PMID:
10517872
11.

Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma.

Costea DE, Hills A, Osman AH, Thurlow J, Kalna G, Huang X, Pena Murillo C, Parajuli H, Suliman S, Kulasekara KK, Johannessen AC, Partridge M.

Cancer Res. 2013 Jul 1;73(13):3888-901. doi: 10.1158/0008-5472.CAN-12-4150. Epub 2013 Apr 18.

12.

Differential knockdown of TGF-β ligands in a three-dimensional co-culture tumor- stromal interaction model of lung cancer.

Horie M, Saito A, Noguchi S, Yamaguchi Y, Ohshima M, Morishita Y, Suzuki HI, Kohyama T, Nagase T.

BMC Cancer. 2014 Aug 9;14:580. doi: 10.1186/1471-2407-14-580.

13.

Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line.

Hasina R, Matsumoto K, Matsumoto-Taniura N, Kato I, Sakuda M, Nakamura T.

Br J Cancer. 1999 Aug;80(11):1708-17.

14.

Regulation of HGF and SDF-1 expression by oral fibroblasts--implications for invasion of oral cancer.

Daly AJ, McIlreavey L, Irwin CR.

Oral Oncol. 2008 Jul;44(7):646-51. Epub 2007 Nov 9.

PMID:
17996483
15.

Tumor-stroma interactions reduce the efficacy of adenoviral therapy through the HGF-MET pathway.

Yasui T, Ohuchida K, Zhao M, Onimaru M, Egami T, Fujita H, Ohtsuka T, Mizumoto K, Tanaka M.

Cancer Sci. 2011 Feb;102(2):484-91. doi: 10.1111/j.1349-7006.2010.01783.x. Epub 2010 Nov 24.

16.
17.

Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway.

Ide T, Kitajima Y, Miyoshi A, Ohtsuka T, Mitsuno M, Ohtaka K, Koga Y, Miyazaki K.

Int J Cancer. 2006 Dec 15;119(12):2750-9.

18.

A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells.

Sempere LF, Gunn JR, Korc M.

Cancer Biol Ther. 2011 Aug 1;12(3):198-207. Epub 2011 Aug 1.

19.

Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ.

Jedeszko C, Victor BC, Podgorski I, Sloane BF.

Cancer Res. 2009 Dec 1;69(23):9148-55. doi: 10.1158/0008-5472.CAN-09-1043. Epub 2009 Nov 17.

20.

Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion.

Grugan KD, Miller CG, Yao Y, Michaylira CZ, Ohashi S, Klein-Szanto AJ, Diehl JA, Herlyn M, Han M, Nakagawa H, Rustgi AK.

Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):11026-31. doi: 10.1073/pnas.0914295107. Epub 2010 Jun 1.

Items per page

Supplemental Content

Write to the Help Desk